Literature DB >> 12697679

Isolation of the novel human guanine nucleotide exchange factor Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF) and of C-terminal SGEF, an N-terminally truncated form of SGEF, the expression of which is regulated by androgen in prostate cancer cells.

Heng Qi1, Andréa Fournier, Josée Grenier, Catherine Fillion, Yvan Labrie, Claude Labrie.   

Abstract

In searching for androgen-responsive genes in human prostate cancer cells, we have isolated two cDNAs that encode alternate forms of a novel Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF). The SGEF mRNA is widely expressed in human tissues, and the predicted 871-amino acid SGEF protein contains Dbl homology and pleckstrin homology domains as well as an N-terminal proline-rich domain, a C-terminal Src homology 3 domain, and two nuclear localization signals. The second cDNA encodes a 139-amino acid N-terminally truncated form of SGEF designated C-terminal SGEF (CSGEF). In contrast to SGEF, CSGEF mRNA expression is restricted to prostate and liver. Moreover, CSGEF expression is up-regulated by androgens in LNCaP cells, whereas that of SGEF is not. Up-regulation of CSGEF was sensitive to actinomycin D but did not require new protein synthesis. The SGEF gene is located on chromosome 3q25.2 and consists of at least 15 exons. Based on the structure of the SGEF and CSGEF cDNAs, we deduced that CSGEF expression is controlled by an alternate androgen-responsive promoter of the SGEF gene. We hypothesize that SGEF is a ubiquitous regulator of Rho guanosine triphosphatases, whereas CSGEF may function as an androgen-induced regulator of Rho guanosine triphosphatase activity in epithelial cells of the human prostate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697679     DOI: 10.1210/en.2002-220984

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Salmonella: from pathogenesis to therapeutics.

Authors:  Erin C Boyle; Jennifer L Bishop; Guntram A Grassl; B Brett Finlay
Journal:  J Bacteriol       Date:  2006-12-22       Impact factor: 3.490

2.  RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.

Authors:  Lucy J Schmidt; Kelly Duncan; Neelu Yadav; Kevin M Regan; Alissa R Verone; Christine M Lohse; Elena A Pop; Kristopher Attwood; Gregory Wilding; James L Mohler; Thomas J Sebo; Donald J Tindall; Hannelore V Heemers
Journal:  Mol Endocrinol       Date:  2012-03-28

3.  SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis.

Authors:  Shawn M Ellerbroek; Krister Wennerberg; William T Arthur; Jill M Dunty; Dan R Bowman; Kris A DeMali; Channing Der; Keith Burridge
Journal:  Mol Biol Cell       Date:  2004-05-07       Impact factor: 4.138

4.  SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.

Authors:  Shannon P Fortin Ensign; Alison Roos; Ian T Mathews; Harshil D Dhruv; Serdar Tuncali; Jann N Sarkaria; Marc H Symons; Joseph C Loftus; Michael E Berens; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2016-01-13       Impact factor: 5.852

5.  The invasive capacity of HPV transformed cells requires the hDlg-dependent enhancement of SGEF/RhoG activity.

Authors:  Vanitha Krishna Subbaiah; Paola Massimi; Siaw Shi Boon; Michael P Myers; Lisa Sharek; Rafael Garcia-Mata; Lawrence Banks
Journal:  PLoS Pathog       Date:  2012-02-23       Impact factor: 6.823

6.  Spaceflight alters the gene expression profile of cervical cancer cells.

Authors:  Zhi-Jie Zhang; Yong-Qing Tong; Jia-Jia Wang; Cheng Yang; Guo-Hua Zhou; Yue-Hui Li; Ping-Li Xie; Jin-Yue Hu; Guan-Cheng Li
Journal:  Chin J Cancer       Date:  2011-11-18

Review 7.  Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.

Authors:  Shannon Patricia Fortin Ensign; Ian T Mathews; Marc H Symons; Michael E Berens; Nhan L Tran
Journal:  Front Oncol       Date:  2013-10-04       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.